Wealthfront Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.36M | Sell |
81,269
-4,994
| -6% | -$403K | 0.01% | 396 |
|
|
2026
Q1 | $7.47M | Sell |
86,263
-4,552
| -5% | -$436K | 0.02% | 330 |
|
|
2025
Q4 | $8.72M | Buy |
90,815
+4,272
| +5% | +$415K | 0.02% | 278 |
|
|
2025
Q3 | $8.24M | Buy |
86,543
+11,104
| +15% | +$1.02M | 0.02% | 278 |
|
|
2025
Q2 | $6.58M | Sell |
75,439
-10,566
| -12% | -$896K | 0.02% | 317 |
|
|
2025
Q1 | $7.73M | Buy |
86,005
+24,000
| +39% | +$2.15M | 0.02% | 250 |
|
|
2024
Q4 | $4.95M | Buy |
62,005
+30
| +0% | +$2.6K | 0.01% | 333 |
|
|
2024
Q3 | $5.58M | Buy |
61,975
+196
| +0.3% | +$16.5K | 0.02% | 277 |
|
|
2024
Q2 | $4.86M | Sell |
61,779
-10,576
| -15% | -$867K | 0.02% | 276 |
|
|
2024
Q1 | $6.31M | Buy |
72,355
+9,677
| +15% | +$826K | 0.02% | 221 |
|
|
2023
Q4 | $5.16M | Sell |
62,678
-26,556
| -30% | -$2.02M | 0.02% | 236 |
|
|
2023
Q3 | $6.99M | Sell |
89,234
-14,394
| -14% | -$1.2M | 0.03% | 161 |
|
|
2023
Q2 | $9.13M | Buy |
103,628
+17,392
| +20% | +$1.5M | 0.04% | 133 |
|
|
2023
Q1 | $6.95M | Buy |
86,236
+53,522
| +164% | +$4.36M | 0.03% | 160 |
|
|
2022
Q4 | $2.54M | Sell |
32,714
-38,055
| -54% | -$3.08M | 0.01% | 344 |
|
|
2022
Q3 | $5.71M | Buy |
70,769
+4,045
| +6% | +$364K | 0.03% | 155 |
|
|
2022
Q2 | $5.99M | Sell |
66,724
-29,756
| -31% | -$3.01M | 0.03% | 160 |
|
|
2022
Q1 | $10.7M | Buy |
96,480
+34,461
| +56% | +$3.64M | 0.05% | 92 |
|
|
2021
Q4 | $6.42M | Sell |
62,019
-35,940
| -37% | -$4.16M | 0.03% | 156 |
|
|
2021
Q3 | $12.3M | Buy |
97,959
+17,429
| +22% | +$2.26M | 0.06% | 67 |
|
|
2021
Q2 | $10M | Buy |
80,530
+2,288
| +3% | +$287K | 0.05% | 71 |
|
|
2021
Q1 | $9.24M | Buy |
78,242
+1,701
| +2% | +$199K | 0.05% | 70 |
|
|
2020
Q4 | $8.97M | Buy |
76,541
+3,267
| +4% | +$360K | 0.05% | 62 |
|
|
2020
Q3 | $7.62M | Buy |
73,274
+16,566
| +29% | +$1.66M | 0.05% | 70 |
|
|
2020
Q2 | $5.2M | Sell |
56,708
-7,616
| -12% | -$730K | 0.04% | 79 |
|
|
2020
Q1 | $5.8M | Buy |
64,324
+29,320
| +84% | +$3.12M | 0.05% | 64 |
|
|
2019
Q4 | $3.97M | Buy |
35,004
+1,074
| +3% | +$118K | 0.03% | 99 |
|
|
2019
Q3 | $3.69M | Buy |
33,930
+4,564
| +16% | +$476K | 0.03% | 94 |
|
|
2019
Q2 | $2.86M | Sell |
29,366
-3,800
| -11% | -$347K | 0.02% | 113 |
|
|
2019
Q1 | $3.02M | Sell |
33,166
-11,278
| -25% | -$1.01M | 0.03% | 100 |
|
|
2018
Q4 | $4.04M | Buy |
+44,444
| New | +$4.15M | 0.04% | 75 |
|
Other funds holding MDT
Wealthfront Advisers's MDT Position: Q2 2026 in Review
Wealthfront Advisers reduced its Medtronic (MDT) stake by 5.8% in Q2 2026, selling an estimated $403K and leaving 81,269 shares worth $6.36M. The position accounts for 0.01% of the portfolio, ranked #396.
Wealthfront Advisers first reported a position in MDT in Q4 2018 and has held it in 31 quarters since. The position peaked at $12.3M in Q3 2021. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Wealthfront Advisers held 81,269 shares of Medtronic worth $6.36M as of Q2 2026.
- Wealthfront Advisers sold 4,994 Medtronic shares in Q2 2026, an estimated $403K.
- Medtronic made up 0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #396 holding.
- Wealthfront Advisers first reported a position in Medtronic in Q4 2018 and has held it in 31 quarters since.
- Wealthfront Advisers's Medtronic position peaked at $12.3M in Q3 2021.
- 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.